Artisan Partners shares fall after TD Cowen cuts price target
Artisan Partners shares fell 3.3% after TD Cowen cut its target to $33. Preliminary assets under management missed the analyst’s estimate.
APAMArtisan Partners
market news
energy, macro and geopolitical news for traders, with market context and links to the original sources.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
FormFactor shares gain after collaboration deal with Teradyne
FormFactor and Teradyne will work to accelerate semiconductor test solutions. Teradyne is also making a strategic $300 million equity investment.
FormFactorTeradyne
Syndax to Halt Axatilimab Development After Fibrosis Trial Miss
Newsmetry API reports that Syndax’s axatilimab missed the main Phase 2 goal in idiopathic pulmonary fibrosis, ending plans for further development.
Syndax PharmaceuticalsAxatilimab
RTX advances naval radar, Coyote interceptor and Vietjet support
RTX reported naval radar software work, three Coyote interceptor tests and broader Collins Aerospace maintenance coverage for 44 Vietjet aircraft.
RTXRaytheonCollins AerospaceVietjet Air
Teradyne to Invest $300 Million in FormFactor Testing Deal
FormFactor and Teradyne will cooperate on semiconductor-testing systems, while Teradyne plans a $300 million strategic equity investment in FormFactor.
FormFactorTeradyne
Navitas and NVIDIA unveil 800 V-to-12 V board for AI data centers
Navitas and NVIDIA developed a 24 kW board that converts 800 VDC directly to 12 VDC for AI data centers, removing the 50 V IBC stage.
NVTSNVDAGaNSiC
Global Ship Lease secures $1 billion syndicated loan facility
Global Ship Lease agreed a seven-year $1 billion loan facility at SOFR plus 1.5% to fund the delivery of 15 new containerships from 2028 to 2030.
Global Ship LeaseGSLSOFR
Nurix Therapeutics swings to Q3 profit on Roche deal proceeds
Nurix Therapeutics reported $673.06 million in third-quarter revenue, lifted by Roche license income and a Sanofi milestone payment.
Nurix Therapeutics
US stocks finish mixed as earnings and key data approach
The S&P 500 and Nasdaq slipped as technology shares fell and oil rallied. Investors now await bank results and the week’s inflation reports.
S&P 500NasdaqDow JonesWTIBrentUS equities
HCLTech beats forecasts as quarterly growth hits three-year low
HCLTech reported $3.72 billion in revenue, above estimates, but September-quarter growth slowed to its weakest level in three years.
HCLTechTata Consultancy ServicesAccentureUSD/INR
US Corn and Soy Basis Holds Mostly Steady as Harvest Gains Pace
US corn and soybean basis bids were largely unchanged as harvest accelerated, while CBOT corn rose and soybean futures finished lower.
CBOT December corn (CZ26)CBOT November soybeans (SX26)US corn basisUS soybean basis
Bitcoin Falls Below $83,000 as Energy Truce Quickly Unravels
Bitcoin fell below $83,000 after fresh Russian strikes on Ukraine’s energy system cast doubt on Trump’s proposed truce ahead of U.S. CPI data.
BitcoinBrentU.S. Treasury yieldsU.S. dollar
Nasdaq slips as oil jumps and investors await bank earnings
US stocks ended mixed as the Nasdaq fell 0.44% after oil prices surged. Investors awaited bank earnings, inflation data and retail sales figures.
Nasdaq CompositeS&P 500Dow Jones Industrial AverageWTIMicrosoftUS Treasury yields
Derive forum weighs plan to pursue US derivatives expansion
A Derive governance proposal seeks approval for legal and regulatory work, plus treasury funding, to explore entry into US-regulated derivatives markets.
Derive
Equity Bancshares seen earning $1.29 per share for the quarter
Equity Bancshares is expected to report revenue of $85.059 million and earnings of $1.29 a share for the quarter ended September 30.
Equity Bancshares Inc
Savara to Present Molgramostim Data at CHEST 2026 Conference
Savara will present clinical data on molgramostim for autoimmune pulmonary alveolar proteinosis at CHEST 2026 in Phoenix, Arizona.
Savara Inc.molgramostim
Lake Street Cuts Pelthos Therapeutics Price Target to $40
Lake Street maintained its Buy rating on Pelthos Therapeutics while lowering the stock’s price target to $40.00 per share from $50.00.
PTHS
Maxim Group Lifts Price Targets for American Bitcoin and Strive
Maxim Group kept Buy ratings on American Bitcoin and Strive while raising their share-price targets to $16 and $37, respectively.
ABTCASST
NOG sees third-quarter capital spending up to $253 million
Northern Oil and Gas reported 1,060 net acres acquired, capital spending of up to $253 million and estimated third-quarter hedge losses.
NOGWTI crude oilNatural gas
Barclays Raises Marathon Petroleum Price Target to $488
Barclays lifted Marathon Petroleum’s price target from $321.00 to $488.00 per share while maintaining an Overweight rating, Newsmetry API reports via Benzinga.
MPCMarathon Petroleum